ChemoCentryx has revealed its IPO terms: 4 mn shares at $14 to$16. The company is hoping to raise $60 mn and is looking to trade on NASDAQ under the symbol CCXI. Its lead underwriters are JP Morgan and C)" href="http://www.insideipo.com/tag/citigroup">Citigroup. According to Renaissance Capital, ChemoCentryx is the fourth biopharm to set its IPO terms this month.
Click here for FREE email alerts from Inside IPO >>
Source: Renaissance Capital
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in